Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1058.55
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 24-Mar-2026
NAV [Rs.]
: 22.8176
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.58 | -1.75 | -2.1 | 0.39 | 2.65 | 24.22 | - | 10.23 |
| Category Avg | -3.14 | -9.37 | -9.79 | -2.24 | 10.08 | 17.25 | 12.31 | 9.03 |
| Category Best | 3.08 | 2.85 | 10.24 | 67.59 | 126.82 | 45.94 | 34.62 | 156.93 |
| Category Worst | -11.64 | -15.95 | -89.76 | -83.5 | -23.07 | 2.35 | 4.25 | -26.24 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.93 | 1336393 | 232.13 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.71 | 160366 | 102.77 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.35 | 769095 | 98.92 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 9.04 | 710091 | 95.73 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.65 | 305956 | 70.42 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.40 | 132001 | 57.20 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 4.98 | 490363 | 52.75 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.07 | 353003 | 43.08 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.93 | 73849 | 41.64 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.84 | 190059 | 40.60 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.32 | 900737 | 35.11 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.03 | 142755 | 32.08 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.75 | 315820 | 29.10 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.53 | 175415 | 26.81 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.00 | 103211 | 21.19 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.73 | 100444 | 18.30 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.65 | 6589 | 17.48 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.50 | 53166 | 15.91 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.34 | 104259 | 14.19 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.15 | 780928 | 12.19 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
